Enlarged Prostate (Benign Prostatic Hyperplasia)

What is Enlarged prostate (benign prostatic hyperplasia)?

Benign prostatic hyperplasia (BPH), commonly called an enlarged prostate, is a non‑cancerous increase in the size of the prostate gland. The prostate surrounds the urethra just below the bladder, so when it grows it can compress the urethra and interfere with normal urine flow. BPH is extremely common, affecting roughly 50 % of men by age 60 and up to 90 % of men over 80 years old [Mayo Clinic].

Common Causes

While the exact trigger for prostate cell proliferation is not fully understood, several conditions and risk factors are consistently linked to BPH development:

• Age – Hormonal changes after middle age favor prostate growth.
• Androgen hormones – Dihydrotestosterone (DHT) stimulates prostate cell division.
• Family history – Men with a father or brother who had BPH are at higher risk.
• Obesity – Excess abdominal fat alters hormone metabolism and increases inflammation.
• Metabolic syndrome – Diabetes, hypertension, and high cholesterol have been linked to BPH.
• Inactivity – Sedentary lifestyles are associated with greater prostate enlargement.
• Dietary factors – High‑fat, low‑fiber diets and excessive red‑meat consumption may promote growth.
• Alcohol & caffeine – Irritate the bladder and may worsen urinary symptoms.
• Chronic prostatitis – Ongoing inflammation can contribute to tissue remodeling.
• Hormone‑disrupting medications – Certain drugs (e.g., some antihistamines) can affect bladder function.

Associated Symptoms

Most men with BPH experience lower urinary tract symptoms (LUTS). Common complaints include:

• Frequent urination, especially at night (nocturia)
• Urgency – a sudden, strong need to void
• Difficulty starting the urine stream (hesitancy)
• Weak or interrupted stream
• Feeling of incomplete bladder emptying
• Dribbling after finishing urination
• Post‑void residual urine (urine left in the bladder)

Some men also notice a feeling of pressure in the lower abdomen or perineum. While BPH itself is not painful, the bladder may become stretched, leading to discomfort.

When to See a Doctor

Because urinary symptoms can signal other conditions (e.g., urinary tract infection, bladder stones, or prostate cancer), it’s important to seek professional evaluation when you notice any of the following:

• Urination that takes longer than 30 seconds to start.
• More than two nighttime trips to the bathroom.
• Weak or “splintered” stream that does not improve.
• Persistent urgency or involuntary leakage (urgency incontinence).
• Visible blood in the urine or semen.
• Painful urination or flank pain (could indicate infection or kidney involvement).
• Sudden worsening of symptoms after a period of stability.

Diagnosis

Diagnosis of BPH is clinical, supported by simple office tests:

Medical History & Physical Exam

• Symptom questionnaires – The International Prostate Symptom Score (IPSS) quantifies severity.
• Digital rectal exam (DRE) – Allows the clinician to feel prostate size, shape, and consistency.

Laboratory & Imaging Studies

• Urinalysis – Rules out infection or blood.
• Prostate‑specific antigen (PSA) test – Elevated PSA can be due to BPH, inflammation, or cancer; values guide further work‑up.
• Ultrasound – Trans‑abdominal or trans‑rectal ultrasound measures prostate volume and post‑void residual urine.
• Uroflowmetry – Records the speed and volume of urine flow; a reduced peak flow suggests obstruction.
• Cystoscopy (in selected cases) – Direct visualization of the urethra and bladder.

Additional Tests (if indicated)

• Urodynamic studies – assess bladder pressure and compliance.
• Pelvic MRI – rarely needed but can differentiate BPH from malignancy when imaging is ambiguous.

Treatment Options

Therapy is individualized based on symptom severity, prostate size, and patient preferences.

Watchful Waiting

Men with mild symptoms (IPSS ≤7) often adopt a “wait‑and‑see” approach, monitoring changes every 6–12 months.

Lifestyle & Home Remedies

• Limit fluid intake 2 hours before bedtime to reduce nocturia.
• Avoid bladder irritants – caffeine, alcohol, carbonated drinks, and spicy foods.
• Practice double‑voiding (urinate, wait a minute, then try again) to empty the bladder more completely.
• Timed voiding – scheduled bathroom trips can train the bladder.
• Pelvic floor (Kegel) exercises – improve urinary control.
• Weight loss and regular aerobic exercise can modestly lower symptom scores.

Medication

First‑line pharmacologic agents include:

• Alpha‑blockers (e.g., tamsulosin, alfuzosin) – Relax smooth muscle in the prostate and bladder neck, improving flow within minutes to days.
• 5‑Alpha‑reductase inhibitors (5‑ARI) (e.g., finasteride, dutasteride) – Shrink the prostate by blocking conversion of testosterone to DHT; effects appear after 3–6 months.
• Combination therapy – Alpha‑blocker + 5‑ARI is often more effective for larger prostates (>30 g) [CDC].
• Phosphodiesterase‑5 inhibitors (e.g., tadalafil) – Useful when erectile dysfunction co‑exists.
• Anticholinergics or β‑3 agonists (e.g., mirabegron) – Help if storage symptoms (urgency, frequency) dominate.

Minimally Invasive Procedures

• Trans‑Urethral Resection of the Prostate (TURP) – Gold‑standard surgical removal of prostate tissue; effective for most men with moderate‑to‑severe obstruction.
• Trans‑Urethral Microwave Thermotherapy (TUMT) – Uses heat to ablate excess tissue.
• Trans‑Urethral Needle Ablation (TUNA) – Radiofrequency energy destroys nodules.
• Prostatic Urethral Lift (Urolift) – Small implants hold open the obstructed urethra without cutting tissue.
• Water‑Based Vapor Therapy (Rezūm) – Steam ablation reduces prostate volume.

Surgical Options (for severe or refractory cases)

• Open prostatectomy – Rare, reserved for very large prostates (>80 g).
• Laparoscopic or robotic simple prostatectomy – Minimally invasive alternatives for giant glands.

Prevention Tips

Although age‑related growth cannot be fully prevented, several evidence‑based measures may slow progression:

• Maintain a healthy weight – Obesity is a modifiable risk factor.
• Exercise regularly – At least 150 minutes of moderate aerobic activity per week reduces hormone‑related prostate growth.
• Adopt a balanced diet – Emphasize fruits, vegetables, whole grains, and omega‑3 fatty acids; limit saturated fat and red meat.
• Stay hydrated, but avoid excess evening fluids – Helps regulate bladder habits.
• Limit caffeine and alcohol – Both can worsen urinary urgency.
• Consider regular PSA screening (per physician recommendation) – Early detection of abnormal growth facilitates timely management.
• Manage chronic conditions – Good control of diabetes, hypertension, and dyslipidemia may reduce BPH progression.

Emergency Warning Signs

Key Take‑aways

Benign prostatic hyperplasia is a common, age‑related condition that can significantly affect quality of life. Early recognition of urinary symptoms, routine medical evaluation, and a combination of lifestyle changes, medication, or procedures can effectively control the disease for most men. While BPH is not cancerous, persistent or worsening symptoms warrant professional assessment to rule out other serious conditions.

For personalized guidance, always discuss symptoms and treatment options with a urologist or primary‑care provider.

---

References:

1. Mayo Clinic. Benign Prostatic Hyperplasia (BPH). https://www.mayoclinic.org
2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). BPH. https://www.niddk.nih.gov
3. American Urological Association (AUA) Guideline on the Management of BPH. https://www.aua.org
4. World Health Organization. Non‑communicable diseases: prostate health. https://www.who.int
5. Cleveland Clinic. Benign Prostatic Hyperplasia (BPH) Treatments. https://my.clevelandclinic.org